The EO771 tumor‐bearing mouse model is used to evaluate the role of angiogenesis and to test molecules modulating angiogenesis, especially since this cell line expresses vascular endothelial growth factor (VEGF) receptors 1 and 2.40 This evidence concerns the gene VEGFA and neoplasm.